Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#309 most reported symptom for this vaccine
Thrombocytopenic purpura has been reported 76 times in association with Varicella (Varivax) vaccination in VAERS. This represents 0.1% of all 93,126 reports for this vaccine.
Among these reports, 1 mentioned death (1.32%) and 55 involved hospitalization (72.4%).
Thrombocytopenic purpura is the #309 most frequently reported symptom for Varicella (Varivax) out of 2205 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 76 reports of Thrombocytopenic purpura after Varicella (Varivax) vaccination may seem alarming, but context is critical.
The mortality rate of 1.32% warrants monitoring, though VAERS deaths represent temporal associations, not confirmed causal links.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.